← Back to patent-cliff list
Selonabant
Tier C — Watch / tradeSelonabant
Vernalis Plc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：CB1
Indications (approved)：中毒, Obesity
Regional status
US
Phase I
2025-09-22
EU
Phase II
2021-12-15
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Selonabant?
Approved indications include: 中毒, Obesity.
When does the Selonabant patent expire?
No public expiry year is available for Selonabant yet; this page updates once verified.
How do I get a quote for Selonabant intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06